Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Örebro Severe Traumatic Brain Injury Registry (ÖrSBID): A Prospective Observational Cohort Study

NCT07398274 is registered in ClinicalTrials.gov with András Zoltán Buki as lead sponsor.

NCT NCT07398274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07398274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Örebro Severe Traumatic Brain Injury Registry (ÖrSBID): A Prospective Observational Cohort Study
Lead sponsor
András Zoltán Buki
Phase
Observational
Overall status
Not yet recruiting
Start date
February 8, 2026
Completion date
February 15, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage, ischemic stroke, severe brain injury, severe traumatic brain injury